Search research articles
Contact Us
Filters
Showing results (31-40 of 124) with videos related to
Page
of 13
Sort By:
European Journal of Cancer & Clinical Oncology
|
October 1, 1983
Prognostic significance of pretreatment serum beta 2-microglobulin levels in multiple myeloma
J H Scarffe, H Anderson, M K Palmer, et al.
British Journal of Cancer
|
April 1, 1980
Colchicine ultrasensitivity of peripheral-blood lymphocytes from patients with non-Hodgkin's lymphoma
J H Scarffe, J Prudhoe, J V Garrett, et al.
Medical and Pediatric Oncology
|
January 1, 1983
Gastrointestinal involvement with myeloma
W J Benson, J H Scarffe, B Houwen, et al.
Clinical Chemistry
|
November 1, 1982
Radioimmunoassay of free light chains of immunoglobulins in urine
E L Robinson, E Gowland, I D Ward, et al.
Blood
|
August 25, 2001
Detection of N-Ras codon 61 mutations in subpopulations of tumor cells in multiple myeloma at presentation
N Kalakonda, D G Rothwell, J H Scarffe, et al.
Hematological Oncology
|
January 1, 1988
Experience with the Portacath
M E Lambert, G A Chadwick, A McMahon, et al.
Cancer Treatment Reports
|
December 1, 1987
Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor
D B Smith, J H Scarffe, J Wagstaff, et al.
Immunology Series
|
January 1, 1990
Clinical application of hematopoietic growth factors
W P Steward, J H Scarffe, T M Dexter, et al.
Hematological Oncology
|
October 1, 1986
Non-secretory multiple myeloma: a report of 13 cases with a review of the literature
D B Smith, M Harris, E Gowland, et al.
British Heart Journal
|
June 1, 1992
Failure of balloon dilatation of the pulmonary valve in carcinoid pulmonary stenosis
S C Grant, J H Scarffe, R D Levy, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 124) with videos related to
Sort By:
Page
of 13
European Journal of Cancer & Clinical Oncology
|
October 1, 1983
Prognostic significance of pretreatment serum beta 2-microglobulin levels in multiple myeloma
J H Scarffe, H Anderson, M K Palmer, et al.
British Journal of Cancer
|
April 1, 1980
Colchicine ultrasensitivity of peripheral-blood lymphocytes from patients with non-Hodgkin's lymphoma
J H Scarffe, J Prudhoe, J V Garrett, et al.
Medical and Pediatric Oncology
|
January 1, 1983
Gastrointestinal involvement with myeloma
W J Benson, J H Scarffe, B Houwen, et al.
Clinical Chemistry
|
November 1, 1982
Radioimmunoassay of free light chains of immunoglobulins in urine
E L Robinson, E Gowland, I D Ward, et al.
Blood
|
August 25, 2001
Detection of N-Ras codon 61 mutations in subpopulations of tumor cells in multiple myeloma at presentation
N Kalakonda, D G Rothwell, J H Scarffe, et al.
Hematological Oncology
|
January 1, 1988
Experience with the Portacath
M E Lambert, G A Chadwick, A McMahon, et al.
Cancer Treatment Reports
|
December 1, 1987
Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor
D B Smith, J H Scarffe, J Wagstaff, et al.
Immunology Series
|
January 1, 1990
Clinical application of hematopoietic growth factors
W P Steward, J H Scarffe, T M Dexter, et al.
Hematological Oncology
|
October 1, 1986
Non-secretory multiple myeloma: a report of 13 cases with a review of the literature
D B Smith, M Harris, E Gowland, et al.
British Heart Journal
|
June 1, 1992
Failure of balloon dilatation of the pulmonary valve in carcinoid pulmonary stenosis
S C Grant, J H Scarffe, R D Levy, et al.
Page
of 13